These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 12238082)

  • 1. [Slowly progressive IDDM (slowly progressive type 1 diabetes)].
    Kobayashi T
    Nihon Rinsho; 2002 Jul; 60 Suppl 7():413-7. PubMed ID: 12238082
    [No Abstract]   [Full Text] [Related]  

  • 2. [Slowly progressive IDDM (SPIDDM)].
    Kobayashi T
    Nihon Rinsho; 1997 Nov; 55 Suppl():604-7. PubMed ID: 9434535
    [No Abstract]   [Full Text] [Related]  

  • 3. The pathogenesis, prediction, and prevention of insulin-dependent diabetes mellitus.
    Muir A; Schatz DA; Maclaren NK
    Endocrinol Metab Clin North Am; 1992 Jun; 21(2):199-219. PubMed ID: 1612064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunopathological and genetic features in slowly progressive insulin-dependent diabetes mellitus and latent autoimmune diabetes in adults.
    Kobayashi T; Tanaka S; Harii N; Aida K; Shimura H; Ohmori M; Kanesige M; Shimada A; Maruyama T
    Ann N Y Acad Sci; 2006 Oct; 1079():60-6. PubMed ID: 17130533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. beta-Cell death during progression to diabetes.
    Mathis D; Vence L; Benoist C
    Nature; 2001 Dec; 414(6865):792-8. PubMed ID: 11742411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Contribution of Japanese researchers to the progress of studies in endocrinology and metabolism in the field of internal medicine in the last 100 years: Slowly progressive insulin-dependent diabetes mellitus (SPIDDM)].
    Kobayashi T
    Nihon Naika Gakkai Zasshi; 2002 Apr; 91(4):1152-4. PubMed ID: 12056010
    [No Abstract]   [Full Text] [Related]  

  • 7. [Slowly progressive IDDM (SPIDDM)].
    Kobayashi T; Kosaka K
    Nihon Rinsho; 1991 Feb; 49 Suppl():412-7. PubMed ID: 2033832
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prevention strategy of beta-cell failure in ICA-positive NIDDM].
    Kobayashi T
    Nihon Rinsho; 1997 Nov; 55 Suppl():765-8. PubMed ID: 9434561
    [No Abstract]   [Full Text] [Related]  

  • 9. Progression of autoimmune diabetes: slowly progressive insulin-dependent diabetes mellitus or latent autoimmune diabetes of adult.
    Beyan H; Ola T; David R; Leslie G
    Ann N Y Acad Sci; 2006 Oct; 1079():81-9. PubMed ID: 17130535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TLR9 blockade inhibits activation of diabetogenic CD8+ T cells and delays autoimmune diabetes.
    Zhang Y; Lee AS; Shameli A; Geng X; Finegood D; Santamaria P; Dutz JP
    J Immunol; 2010 May; 184(10):5645-53. PubMed ID: 20393135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in adhesion markers, activation markers, and TcR in islet infiltrating vs. peripheral lymphocytes in the NOD mouse.
    Goldrath AW; Barber L; Chen KE; Alters SE
    J Autoimmun; 1995 Apr; 8(2):209-20. PubMed ID: 7612149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Type 1 diabetes mellitus and immunopathology].
    Koike T
    Nihon Rinsho; 2002 Jul; 60 Suppl 7():399-406. PubMed ID: 12238080
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical trials. Diabetes' brave new world.
    Couzin J
    Science; 2003 Jun; 300(5627):1862-5. PubMed ID: 12817117
    [No Abstract]   [Full Text] [Related]  

  • 14. Islet cell autoantibodies: pathobiology and clinical applications.
    Vardi P; Dibella EE; Pasquarello TJ; Srikanta S
    Diabetes Care; 1987; 10(5):645-56. PubMed ID: 3315517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Slowly progressive IDDM].
    Kobayashi T
    Nihon Rinsho; 1999 Mar; 57(3):607-11. PubMed ID: 10199141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological heterogeneity in type I diabetes: presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease.
    Seissler J; de Sonnaville JJ; Morgenthaler NG; Steinbrenner H; Glawe D; Khoo-Morgenthaler UY; Lan MS; Notkins AL; Heine RJ; Scherbaum WA
    Diabetologia; 1998 Aug; 41(8):891-7. PubMed ID: 9726590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies associated with presymptomatic insulin-dependent diabetes mellitus in women.
    Whittingham S; Byron SL; Tuomilehto J; Zimmet PZ; Myers MA; Vidgren G; Rowley MJ; Feeney SJ; Koskela P; Tuomilehto-Wolf E; Mackay IR
    Diabet Med; 1997 Aug; 14(8):678-85. PubMed ID: 9272595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Islet-infiltrating T cell clones from non-obese diabetic mice that promote or prevent accelerated onset diabetes.
    Pankewycz O; Strom TB; Rubin-Kelley VE
    Eur J Immunol; 1991 Apr; 21(4):873-9. PubMed ID: 1902177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunogenetics and new therapies in type I diabetes mellitus].
    Gannage-Yared MH
    J Med Liban; 1999; 47(2):139-43. PubMed ID: 10410471
    [No Abstract]   [Full Text] [Related]  

  • 20. Cellular and humoral autoimmunity in insulin-dependent diabetes mellitus.
    Scherbaum WA; Seissler J
    Exp Clin Endocrinol Diabetes; 1995; 103 Suppl 2():88-94. PubMed ID: 8839261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.